Medicare Advantage vs Medigap (Supplement Plans): Detailed Cost, Network & Drug Coverage Comparison (2026)

1. The Foundation: Original Medicare (Part A and Part B) Explained

Administered directly by the federal Centers for Medicare & Medicaid Services (CMS), Original Medicare forms the public baseline for healthcare coverage in retirement:

• Medicare Part A (Hospital Insurance): Covers inpatient hospital stays, skilled nursing facility care, hospice care, and limited home healthcare. Most Americans receive Part A premium-free if they or their spouse paid Medicare payroll taxes for at least 40 calendar quarters (10 years). However, Part A enforces a substantial inpatient hospital deductible per benefit period ($1,632+ in baseline statutory tiers), alongside escalating daily coinsurance for prolonged stays.
• Medicare Part B (Medical Insurance): Covers outpatient medical visits, physician fees, preventive screenings, ambulance transport, durable medical equipment, and outpatient chemotherapy. Part B requires a standard monthly premium (adjusted higher for high earners via Income-Related Monthly Adjustment Amount, or IRMAA). After meeting a modest annual Part B deductible ($240+), the beneficiary is responsible for a mandatory 20% Coinsurance on all Medicare-approved charges.

2. Pathway 1: Original Medicare + Medigap (Supplemental Insurance)

Under the Medigap pathway, the beneficiary remains enrolled in Original Medicare. Private insurance carriers sell standardized supplemental policies that pay the deductibles, copayments, and the 20% coinsurance that Original Medicare leaves behind.

A. The Gold Standard: Plan G and Plan N

By federal law, Medigap plans are standardized into lettered plans (A, B, C, D, F, G, K, L, M, N). Because Plan F was phased out for newly eligible beneficiaries, Plan G and Plan N dominate the marketplace:

• Medigap Plan G: The most comprehensive coverage available. Plan G pays 100% of all Medicare-approved expenses after the beneficiary pays the modest annual Part B deductible out-of-pocket. Once that small deductible is satisfied, the patient experiences 100% first-dollar coverage—zero copays for doctor visits, hospitalizations, or complex surgeries. Plan G also covers Part B “Excess Charges” (when a provider charges up to 15% above the Medicare-approved fee schedule).
• Medigap Plan N: A cost-effective alternative. Plan N offers lower monthly premiums in exchange for minor cost-sharing: up to a $20 copay for certain office visits, up to a $50 copay for emergency room visits that do not lead to an inpatient admission, and the beneficiary is responsible for Part B excess charges.

3. Pathway 2: Medicare Advantage (Part C) – Managed Care Managed by Private Insurers

When an individual enrolls in a Medicare Advantage (Part C) plan, they voluntarily opt out of direct federal administration. Instead, the federal government pays a fixed capitated monthly subsidy to private commercial insurance conglomerates (such as UnitedHealthcare, Humana, Aetna, or Elevance Health) to administer the beneficiary’s healthcare benefits.

Decision Metric	Original Medicare + Medigap (Plan G/N)	Medicare Advantage (Part C HMO/PPO)
Monthly Premium Cost	Higher ($130 to $250+ per month depending on age, gender, tobacco, and state).	Low to $0.00 per month (beneficiary still pays standard Part B premium).
Provider Network Freedom	Unrestricted Nationwide: Any doctor, hospital, or specialist in the US accepting Medicare (over 93% of doctors).	Restricted Local Network: HMOs require staying in-network; PPOs impose severe out-of-network copay surcharges.
Specialist Referrals	Never Required: Direct access to specialized oncologists, cardiologists, and surgeons anywhere in the nation.	HMO plans mandate obtaining a primary care physician (PCP) gatekeeper referral first.
Prior Authorization Hurdles	Virtually Zero: If the physician deems the treatment medically necessary and Medicare approves, it is paid.	Extensive: Over 99% of enrollees face corporate prior authorization approvals for MRIs, surgeries, SNF care, and chemotherapy.
Out-of-Pocket Predictability	Nearly 100% predictable; out-of-pocket costs capped at the small Part B deductible ($240/yr).	Variable copays that can reach the federal Maximum Out-of-Pocket (MOOP) cap (up to $8,850+ in-network).
Prescription Drug Coverage	Requires purchasing a standalone Part D Drug Plan ($15–$50/mo).	Typically bundled directly into the Part C plan (MA-PD).

Managing high medical expenses in retirement often requires liquidating home equity, which seniors frequently execute through federally insured programs, as analyzed in our guide on Reverse Mortgages (HECM) for Seniors: Eligibility & Risks.

4. The Hidden Reality of Prior Authorizations in Medicare Advantage

A critical systemic difference between Original Medicare and Medicare Advantage lies in the administrative utilization management techniques employed by private insurers:

According to an exhaustive investigation published by the U.S. Department of Health and Human Services Office of Inspector General (OIG), Medicare Advantage insurers systematically deny tens of thousands of prior authorization requests annually that meet Medicare coverage rules. Common service categories subjected to aggressive prior authorization denials include:

• Advanced diagnostic neuro-imaging (CT scans, brain MRIs, PET scans).
• Post-acute skilled nursing facility (SNF) inpatient rehabilitation following strokes or hip fractures.
• Inpatient acute rehabilitation hospital admissions.
• Expensive specialty injectable cancer therapies and durable medical equipment.

Under Original Medicare paired with Medigap, there are no insurance company claims adjusters reviewing care. If a board-certified physician orders a procedure and the clinical code is covered under standard Medicare guidelines, it is automatically approved and processed. Similar procedural challenges emerge in medical disputes, as discussed in our legal review of Medical Malpractice Standards of Care and Expert Burden of Proof.

5. The Medigap Open Enrollment Period: The Lifetime Guarantee Trap

The single most critical procedural window for any retiree is the Medigap Open Enrollment Period (OEP). This 6-month window begins automatically on the first day of the month in which an individual is both age 65 or older AND enrolled in Medicare Part B:

• Guaranteed Issue Rights: During this 6-month OEP, federal law grants beneficiaries complete “Guaranteed Issue” rights. A private insurance carrier cannot deny coverage, cannot place waiting periods on pre-existing conditions, and cannot charge higher premiums based on health history, cancer diagnoses, diabetes, or heart disease.
• The Underwriting Trap: If a senior chooses a $0 Medicare Advantage plan at age 65, and subsequently develops cancer, heart failure, or severe autoimmune disorders at age 71, they may find their Medicare Advantage network too restrictive. If they attempt to switch back to Original Medicare and purchase a Medigap Plan G, private insurers in 46 states are legally permitted to conduct rigorous medical underwriting. The insurer can review five years of medical charts, charge astronomical premiums, or flatly decline the application. Except in a handful of states with community rating laws (e.g., New York, Connecticut, Massachusetts), seniors are trapped in Medicare Advantage once major chronic illnesses develop.

6. Dual Eligible Special Needs Plans (D-SNPs) and Chronic Condition SNPs

For low-income seniors who qualify for both Medicare and state Medicaid (known as “Dual Eligibles”), specialized Medicare Advantage options exist under CMS regulations:

• Dual Eligible Special Needs Plans (D-SNPs): These plans coordinate Medicare and Medicaid benefits into a single managed system, providing specialized care coordinators, non-emergency medical transportation, food and utility subsidies, and zero out-of-pocket costs for covered medical services.
• Chronic Condition Special Needs Plans (C-SNPs): Tailored specifically for individuals diagnosed with debilitating conditions such as diabetes mellitus, chronic heart failure (CHF), or end-stage renal disease (ESRD), C-SNPs feature provider networks centered around endocrinologists, cardiologists, and nephrologists with custom drug formularies.

7. Prescription Drug Coverage (Part D) and Inflation Reduction Act Caps

Prescription drug coverage under Medicare has undergone dramatic modernization pursuant to the Inflation Reduction Act (IRA):

• The $2,000 Annual Out-of-Pocket Cap: Beginning in 2025 and established permanently for 2026, out-of-pocket prescription drug spending under both standalone Part D plans and Medicare Advantage prescription drug (MA-PD) plans is capped at a strict maximum of $2,000 per calendar year.
• Elimination of the Coverage Gap (“Donut Hole”): The historic coverage gap has been eliminated, simplifying drug cost sharing into an initial deductible phase followed by a standard coinsurance phase until reaching the $2,000 annual ceiling.
• Insulin Pricing Protections: Insulin copayments are permanently capped at a maximum of $35 per 30-day supply across all Medicare drug plans.

8. Frequently Asked Questions (FAQs)

9. Decision Roadmap: Which Pathway Is Right for You?

1. Evaluate Your Financial Liquidity: If you can comfortably afford $150 to $250 per month in premiums to eliminate future medical bill surprises, Medigap Plan G provides superior long-term financial security. If fixed monthly income is severely constrained, a $0 Medicare Advantage plan provides a viable alternative, provided you maintain an emergency fund to cover annual out-of-pocket maximums.
2. Assess Your Chronic Health Profile: If you have complex pre-existing conditions, require specialized oncology care, or travel frequently between states, Original Medicare with Medigap is overwhelmingly recommended.
3. Protect Your 6-Month Open Enrollment Window: Never let your initial Medigap Open Enrollment Period expire without a formal strategic review; missing this window can permanently bar you from supplemental medical underwriting approval.
4. Conduct an Annual Part D Drug Formulary Review: Use Medicare’s official plan finder tool during the Annual Enrollment Period (October 15 to December 7) to ensure your specific medications remain on the most cost-effective tier.